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Background: The Nuclear Factor I (NFI) family of DNA binding proteins (also called CCAAT box transcription factors
or CTF) is involved in both DNA replication and gene expression regulation. Using chromatin immuno-precipitation
and high throughput sequencing (ChIP-Seq), we performed a genome-wide mapping of NFI DNA binding sites in
primary mouse embryonic fibroblasts.
Results: We found that in vivo and in vitro NFI DNA binding specificities are indistinguishable, as in vivo ChIP-Seq
NFI binding sites matched predictions based on previously established position weight matrix models of its in vitro
binding specificity. Combining ChIP-Seq with mRNA profiling data, we found that NFI preferentially associates with
highly expressed genes that it up-regulates, while binding sites were under-represented at expressed but
unregulated genes. Genomic binding also correlated with markers of transcribed genes such as histone
modifications H3K4me3 and H3K36me3, even outside of annotated transcribed loci, implying NFI in the control of
the deposition of these modifications. Positional correlation between + and - strand ChIP-Seq tags revealed that, in
contrast to other transcription factors, NFI associates with a nucleosomal length of cleavage-resistant DNA,
suggesting an interaction with positioned nucleosomes. In addition, NFI binding prominently occurred at
boundaries displaying discontinuities in histone modifications specific of expressed and silent chromatin, such as
loci submitted to parental allele-specific imprinted expression.
Conclusions: Our data thus suggest that NFI nucleosomal interaction may contribute to the partitioning of distinct
chromatin domains and to epigenetic gene expression regulation.
NFI ChIP-Seq and input control DNA data were deposited at Gene Expression Omnibus (GEO) repository under
accession number GSE15844. Gene expression microarray data for mouse embryonic fibroblasts are on GEO
accession number GSE15871.
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Nuclear factor I (NFI) was initially discovered as a cel-
lular factor required for adenovirus DNA replication
[1], where it binds to the origin of replication and
recruits the viral DNA polymerase [2-4]. Subsequent
studies showed NFI to be functionally and structurally
indistinguishable from the sequence-specific CCAAT
box-binding transcription factor CTF [5,6]. When
bound to the promoter regions, NFI was found to act
either as an activator or as a repressor of transcription* Correspondence: pjanic.milos@gmail.com
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reproduction in any medium, provided the or[7-12]. NFI consists of a family of related transcription
and replication factors that comprise the NFIA, NFIB,
NFIC, NFIX polypeptides encoded by four paralogous
genes in mammals [13,14], while orthologous NFI
genes have been annotated in all examined vertebrate
species [15,16]. In addition to the four NFI-coding
genes, the diversity of this family of DNA binding
proteins is further increased by the differential splicing
of the gene transcripts [5,17]. However, all NFI iso-
forms share a homologous N-terminal domain respon-
sible for the sequence specific DNA binding, while
their C-terminal proline-rich regulatory domain differs
between variants [18]. This C-terminal domain is
required for either the activation or the repression oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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has been shown to interact with nucleosomal histone
H3, in vitro and on reporter promoters in transfected
cells [19,20].
This ability of NFI-C to contact histone H3 has been
proposed to alter the interaction of nucleosomal parti-
cles and DNA. For example, mouse mammary tumor
virus (MMTV) LTR contains 6 nucleosomes that are
being positioned after binding of NFI-C to its recogni-
tion site within the virus LTR [21,22]. This nucleosomal
positioning is essential for the inducible response of the
MMTV promoter to the glucocorticoid receptor. These
findings indicated that NFI-C may directly regulate
chromatin dynamics. Recent evidence also showed that
NFI-C can act as a barrier protein that can stop the
spreading of silent chromatin from yeast and human cell
telomeres, and that it may thereby shield telomeric
genes from heterochromatic silencing [20,23,24].
The different NFI isoforms are widely expressed, and
knock-out of the individual genes yielded different
phenotypes in mice, suggesting that its isoforms regu-
late distinct genes [14]. However, all NFI species bind
similar dyad-symmetric TTGGC(N)5GCCAA sequence
motifs as homo- or hetero-dimers [3,18,25,26]. As for
other transcription factors, attempts to model the
binding specificity from few in vitro-assayed binding
sites was met with variable success [27,28]. However,
an NFI weight matrix could be derived from a collec-
tion of over 10,000 binding sites selected using a
SELEX-SAGE approach, and it was shown to provide
reliable and quantitative estimates of NFI binding
affinity and specificity in vitro [29]. However, to which
extent this and other similar tools are capable of
predicting in vivo interactions in the presence of
chromatin and other DNA-binding proteins remains
mostly untested.
In this work, we used chromatin immuno-precipitation
coupled to next generation DNA sequencing (ChIP-Seq)
to map NFI binding locations on the genome of murine
fibroblasts. This indicated that the bioinformatics model
of NFI sequence specificity accurately predicts binding
occurrence in the cell, but that only a subset of the
predicted binding sites are occupied. We also found that
NFI preferentially associates with highly expressed
genes, and that its binding is associated with active
chromatin marks, even on binding sites occurring at
distance from expressed genes, implying that it may
directly control chromatin structure. Using a positional
correlation of ChIP-Seq tags, we observed that NFI-
containing complexes cover a nucleosomal length of
DNA, unlike other DNA-binding proteins. Finally, we
observed that NFI binding is often associated with the
occurrence of genomic boundaries separating distinct
chromatin structures. These findings suggest that theinteraction of NFI with nucleosomal DNA may mediate
chromatin domain barriers at natural genomic locations.
Results and Discussion
Genome-wide mapping of NFI binding sites
Using chromatin immuno-precipitation and a high-
throughput DNA sequencing (ChIP-Seq) approach, we
created a whole-genome map of NFI binding sites. This
was performed using primary mouse embryo fibroblast
(MEF) cells originated from wild-type (wt) and homozy-
gous knock-out (ko) mice in which one of the NFI genes
(nf1-c) was inactivated [30]. From wt cells, we obtained
14,358,325 reads, of which 9,771,440 (68.1%) could be
mapped to unique positions in the genome. For ko cells,
10,809,703 out of 16,330,049 reads (66.3%) could be
mapped to the genome. Our mapping efficiency is
comparable to other ChIP-Seq experiments [31,32].
However, high multiplicity of tags mapping to the same
genome position was observed, indicating that the
material was PCR-amplified from a small founder popu-
lation of DNA fragments. As a consequence, the total
number of genome positions hit by one or more reads
was reduced to 3,351,008 for wt cells, and 3,134,919 for
ko cells.
A similar number of non-precipitated (input) genomic
fragments were also sequenced as a control for potential
biases in the distribution of genomic DNA fragments.
From this DNA preparation, a lower fraction of tags (45%)
could be uniquely mapped to the mouse genome, but
there was also a lower degree of tag multiplicity. Overall,
the 12,029,975 input sequences could be mapped to
4,104,241 unique positions.
In vivo NFI binding sites were identified with the
ChIP-peak program of the ChIP-Seq tools, which is
publicly available via a web interface (see Methods Sec-
tion for details). This tool scans the genome in a sliding
window of a fixed size and reports the center positions
of genomic regions that are enriched in ChIP-Seq tags
[33]. To get a comprehensive picture of NFI binding, we
scanned the genome with different tag count thresholds.
With thresholds of 5, 6, 7 and 8 tags, we obtained
14,487, 4,794, 1,642, and 701 peaks, respectively. These
numbers document a low tag-coverage of binding sites,
which may either reflect a low signal-to-noise ratio or
the dilution of a true signal over a very large number of
in vivo occupied binding sites. There are precedents of
ChIP-Seq experiments with 5 to 10 tags per peak, e.g.
Smad1 analysis in ES cells, where biologically meaning-
ful sequence motif were generated from the peaks [34],
justifying further analysis.
Peak validation by motif enrichment test
In view of the low tag coverage of extracted peaks, we
first wished to obtain evidence that the peaks were
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distribution of the NFI binding site motifs around the
peak center positions in the various peak lists using the
SELEX-based weight matrix shown in Additional file 1:
Figure S1. The results were ensuring, as we observed a
narrow peak centered at the estimated binding site
position at all thresholds (see Figure 1A and 1B and0
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Figure 1B), suggesting that the corresponding peak col-
lections may be contaminated with a larger proportion
false positives. Nevertheless, in absolute numbers this
peak collection is estimated to contain about 5 times
more true sites than the peak list obtained with a
threshold of 8 tags. In order to choose an appropriate
peak threshold, we followed the guidelines of the EN-
CODE consortium [35], which require that a known
binding motif of a transcription factor should be at least
four-fold enriched and occur in at least 10% of the peak
regions extracted from corresponding ChIP-Seq data.
With our data, the lowest tag threshold meeting these
criteria was 6 (enrichment factor 5.3 and motif occur-
rence frequency 17.8%, see Figure 1B). We thus used
this peak threshold for all further analyses unless speci-
fied otherwise.
The peak finding method applied here does not use
input control data for background subtraction nor does
it rank peaks by P-values based on a statistical model.
As this might affect the quality of the resulting peak
sets, we repeated the peak finding step with the widely
used MACS program [35]. The resulting peak lists were
then evaluated with a particular motif enrichment plot
used in a recent benchmarking paper for the same pur-
pose [36]. ChIP-peak was found to outperform MACS
with a rather large margin, especially if the latter pro-
gram was used with default parameters (see Additional
file 1: Figure S4). Regardless of the threshold, the peak
lists obtained with ChIP-peak always contained more
NFI motifs than those obtained with MACS. Somewhat
better results were obtained when a tag shift of 150 bp
was given as an input parameter to MACS (by default,
MACS estimate this parameter from the data). Even
better performance was observed when the input
control was omitted. Usage of an input control thus did
not improve performance of the peak finder. Based in
this observation, we considered it unlikely that another
peak finding method would perform substantially better
on our data than ChIP-peak with optimized parameter
settings.
In vivo NFI binding sites partially overlap predicted
binding sites
We next assessed whether NFI in vivo binding sites spe-
cificity correlates with binding site predictions based on
a weight matrix model determined from in vitro binding
assays using various analytical strategies. To this end,
we first scanned the mouse genome with the NFI weight
matrix previously established from high-throughput
SELEX-SAGE assays (see Additional file 1: Figure S1A).
This matrix was shown previously to accurately com-
pute relative in vitro binding affinities [29]. The genome
scan resulted 12,209 predicted high-affinity binding siteswith a matrix score ≥90 (arbitrary score units, see
Additional file 1: Figure S1B). Almost two million sites
were found with a score threshold of 67, the lowest
value for which in vitro binding activity was observed.
The average counts of ChIP-Seq tags showed a substan-
tial enrichment surrounding the center of the predicted
NFI sites while no increased tag frequency was observed
from the non-precipitated genomic input DNA
(Figure 1A). When using lower matrix score cut-offs
(85 or 80, yielding 61,492 and 231,146 predicted sites,
respectively), a gradual reduction of the correlation was
noted between the predicted sites and ChIP-Seq tags
(see Additional file 1: Figure S5). We conclude that low
scoring predicted sites are less frequently occupied by
the protein in vivo, as would be expected from their
lower predicted affinity.
Next, we focused on the 708 most highly occupied
in vivo NFI sites, which correspond to a threshold of at
least 8 tags, as nearly 40% of these sites colocalized with
a medium-to-high scoring predicted binding sequence
(weight matrix score ≥79; Figure 1B). We next won-
dered whether the remaining 60% co-localize with lower
affinity binding sites. Lowering the score threshold to 67
increased the peak maximum to about 60%, but it sim-
ultaneously raised the background frequency to nearly
20% (see Additional file 1: Figure S6). Consequently,
there was no net gain in motif enrichment when the
weight matrix cut-off value was lowered. Thus, about
half the highly occupied in vivo NFI sites do not co-
localize with a recognizable NFI binding motif.
The chromatin context does not change NFI intrinsic
binding specificity
The partial overlap between binding sites predicted
from an in vitro specificity model and in vivo binding
sites determined by ChIP-Seq could be explained in at
least two different ways. For instance, the in vivo bind-
ing specificity may be similar but not identical to that
for naked DNA. For instance, interactions with histones
and other chromatin proteins could alter the DNA
structure in a way that would change the relative affinity
of the NFI protein to different target sequences. Alter-
natively, the intrinsic sequence specificity may not be
influenced by the chromatin context, but other mechanism
may interfere with the NFI recruiting process, such as
competition with other transcription factors, or the
indirect recruitment of NFI by interactions with other
DNA binding proteins.
To discriminate between these two hypotheses, we
first we analyzed the correlation between weight matrix
scores and ChIP-Seq tag coverage at the highest possible
resolution. To this end, the tag coverage of all predicted
NFI sites with scores ≥67 was determined as follows.
Each plus strand tag was attributed to the closest
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200 bp. The minus strand tags were attributed to the
closest upstream predicted site applying the same
distance constraint. We then grouped the predicted
sites by matrix score, and computed the average tag
coverage for each score class. The tag count was found
to increase exponentially with the weight matrix score
(Figure 1D), which is consistent with the fact that the
weight matrix scores were defined to have a log-linear
relationship to the actual binding affinity [28,29]. The
almost perfect correlation between predicted score and
average tag coverage speaks against chromatin-induced
changes of the in vitro determined binding specificity.
We then tried to directly compare the in vivo and
in vitro binding specificities by generating a new weight
matrix from the ChIP-Seq data with the same computa-
tional method that was used to generate the in vitro
binding specificity matrix (shown as a sequence logo in
Figure 1E). This logo was derived from 5,579 25bp-long
NFI binding sequences obtained with a SELEX-SAGE
experiment [29], using the hidden Markov model-training
program MAMOT (Schütz and Delorenzi 2008) to itera-
tively optimize a weight matrix model starting from the
consensus sequence TTGGCNNNNNGCCAA. Applying
the same procedure to 4,794 200bp-long sequences
centered on the ChIP-seq peaks obtained with a tag
threshold of 6, we obtained the logo shown in Figure 1F.
The sequence logos corresponding to the in vitro and
in vivo binding specificity are almost identical, with the
exception of the first and last nucleotide positions
(Figure 1E and 1F and Additional file 1: Figure S6B).
In parallel, we carried out motif discovery with the
program peak-motifs from the RSA-tools [36], which
yielded an NF1-like motif from all peak lists. In addition,
an AP1-like motif was also obtained from the peak lists
obtained with thresholds of 6, 7 and 8 (see Additional file
2: Table S1). Taken together these findings suggest that
other factors than chromatin accessibility may account for
the imperfect overlap between predicted and observed
in vivo binding sites. In particular, AP1 complexes may be
involved in the indirect recruitment of NFI protein to
those target sites which lack a canonical NFI motif.
Genomic distribution of NFI sites relative to genes
Of the 4,794 binding sites identified with a tag threshold
of 428 occurred within 5 kb upstream of genes, 106 in
protein coding exons, and 232 within 5 kb downstream
of genes (see Additional file 2: Table S2). As expected,
the majority of binding sites occurred in introns and in
intergenic regions (1,966 and 2,138). However, these
NFI-bound sites were not randomly distributed across
the genome, as they appeared more frequently around
genes. Upstream regions, 5’UTR exons and 3’UTR
exons contained the highest binding sites densities, withabout 3.9, 12.3 and 3.3 binding sites per Mb, respect-
ively, while intergenic regions had the lowest density
(about 1.3 binding sites per Mb; see Additional file 2:
Table S2). Overall, NFI genomic distribution resembles
that of many other DNA binding proteins assayed by
ChIP-Seq [34], including the insulator protein CTCF, to
which we will refer below in another context. The distri-
bution of NFI sites is however markedly different from
that of classical promoter-associated transcription
factors such as c-Myc.
Genome-wide mapping of NFI binding sites in NFI-C ko
cells
We carried out similar NFI-C ChIP-Seq experiment with
NFI-C ko MEF cells. Analysis of extracts of such cells
showed a complete absence of the 55 KDa polypeptide
corresponding to the major splice variant of NFI-C, and a
significantly reduced level of other NFI species when
analyzed by Western blotting (see Additional file 1: Figure
S7A and S7B). ChIP-Seq tag counts from NFI-C ko cells
showed slightly reduced occupation of NFI predicted sites
in comparison to the wild type tag set (see Additional file 1:
Figure S7C), which was confirmed by quantitative PCR for
several randomly chosen high-scoring predicted sites (data
not shown). Sequence motif analysis of the strongest
in vivo sites from wt and ko MEF using MEME [37]
revealed a similar most prominent sequence logo (see
Additional file 1: Figure S6), indicating similar binding
specificities for all NFI species, as expected from previous
reports. By extracting peaks and comparing the peak lists
from the two data sets, we found little differences between
in vivo occupancy patterns. We conclude that the same
sites are occupied by an NFI protein family in NFIC wt
and ko cells, but obviously not always by the same NFI
species.
Determination of the length of NFI binding complexes
using ChIP-Seq
High throughput sequencing of DNA fragments may
occur from both extremities of the DNA fragments,
and the corresponding sequence tags will be mapped
to opposite (plus or minus) DNA strands. This was
used to analyze the length of the DNA that is occupied
by the precipitated protein complex, assuming that
DNA cleavage occurs preferentially outside of cross-
linked protein-DNA complexes. Thus, genome-wide
positional correlations between the plus and minus
strand-mapping tags should reveal the average size of
the DNA being protected by the protein complex when
single-end sequencing is used, as performed in this
study (see Additional file 1: Figure S8).
We separated NFI ChIP-Seq tags into datasets com-
prising either the plus or minus strand-mapping tags,
yielding similar tag counts (4,890,670 and 4,880,749,
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biased in this respect. Genome-wide positional correl-
ation between the plus and minus strand tags was made
by assessing the frequency of minus tags at varying
distances from the plus tags. The position-specific
minus tag frequencies were divided by the genome-wide
average frequency for normalization purposes. As a
basis for comparison, we also generated such profiles
for the CTCF and STAT-1 transcription factors, using
previously reported ChIP-Seq datasets [31,38]. The
resulting distributions appear to be Gaussian, with the
peak maximum at 80bp for CTCF and 140bp for STAT1
(Figure 2A,B). The larger spacing between plus and
minus strand tags seen with STAT1 is consistent with
the previous observation that STAT-1 can form dimers
or trimers that occupy larger portions of the DNA
[39,40]. We also assessed the STAT1 control ChIP-Seq
dataset generated from cells not stimulated with inter-
feron, where STAT1 is not activated and does not enter
into the nucleus. This dataset yielded a uniform distri-
bution (Figure 2B), as expected from the absence of
STAT-DNA interactions. The distributions of the
histone H3 trimethylated on lysine 4 (H3K4me3) and of
the H2AZ histone variant showed multiple peaksA
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electrophoresis, and a possible intrinsic size-selection of
the sequencing technology.
This was assessed by performing the positional correl-
ation of the plus and minus tags from the sequencing of
fragmented but non-immunoprecipitated genomic DNA,
which yielded a more diffuse profile with a maximum
at 180 bp, suggesting that chromatin sonication resulted
mostly in mononucleosomal particles (see Additional file 1:
Figure S9). This interpretation was confirmed by releasing
the genomic DNA from cross-linked chromatin proteins
after sonication, and by directly measuring the length of
DNA fragments using scanning atomic force microscopy
(AFM). This assay revealed an overrepresentation of DNA
fragments comprised between 50 and 250 bp, with most
sequences ranging between 100 and 160 bp (see Additional
file 1: Figure S10), implying that the DNA population
used for immunoprecipitation indeed consisted mostly
of mononucleosomal complexes.
Mapping of the polarity of tags surrounding NFI pre-
dicted sites revealed symmetrically distributed profiles of
the plus and minus strand tags around the centers of the
binding sequence dyad (see Additional file 1: Figure S5).
Well-positioned tag distributions were most prominent for
the high-scoring sites, which often correspond to frequently
occupied binding sites, implying that this pattern directly
results from binding site occupancy. The distribution
maxima were clearly separated by approximately 150 bp.
These observations are consistent with the interpretation
that NFI proteins may co-precipitate with nucleosomal
complexes occupying around 150 bp of DNA, although
other interpretation remain possible. Our proposed model
of NFI interaction with the DNA in a nucleosomal protein
complex is shown in the Additional file 1: Figure S11.
NFI associates with open chromatin marks and chromatin
domain boundaries
To test whether NFI may preferentially associate with
the markers of specific chromatin structure, we used
available ChIP-Seq data of histone modifications in
MEF cells [41]. We first separated in vivo-occupied NFI
sites occurring at promoters, within 5kb upstream or
downstream from the RefSeq annotated transcriptional
start sites (TSS), from those mapping elsewhere. Out of
14,487 occupied sites, 2,040 map within 5 kb of RNA
polymerase II TSS in both directions. As expected, these
TSS-associated sites were highly correlated with the
H3K4me3 modification known to occur at the promoters
and enhancers of expressed genes (Figure 3A) [41-43].
Surprisingly, in vivo NFI sites outside TSS were also
associated with this modification, but to a smaller
extent (Figure 3B). The association with H3K4me3
suggested that NFI binding might be associated to the
deposition of this histone mark, for instance at distaltranscriptional enhancers [38] or at chromatin barriers
[44]. Alternatively, it may occur at un-annotated TSS
corresponding to e.g. unknown transcripts and/or at the
TSS of miRNAs, as 3 NFI sites were found to overlap
the promoters of primary miRNA transcripts in the
mouse genome (see Additional files 1: Figure S12 and 2:
Table S3) [45]. The levels of H3K36me3 marker of
transcribed regions increased with increasing distance
from the TSS-proximal in vivo NFI sites (Figure 3A),
which is indicative of the active transcription of these
genes [41]. The level of H3K36me3 and H3K4me3 were
also slightly elevated in the vicinity of NFI binding sites
mapping outside TSS, but they displayed a pattern that
was distinct from the ones observed at protein-coding
or miRNA genes (Figure 3B and Additional file 1: Figure
S12), suggesting that they do not correspond to non-
annotated genes. For comparison, we provide similar
graphics for another transcript factor (Nanog) and
corresponding histone marks in ES cells (Figure 3C-D).
The overall picture is similar with one notable excep-
tion: The major H3K4me3 peak is bimodal, with a mini-
mum right at the center of the binding region. The
different peak shapes lend further support to our
hypothesis that NFI binds to nucleosomes, in contrast
to most other transcription factors, including Nanog,
which bind to nucleosome-free regions.
It has been shown that NFI may act to prevent the
propagation of silent chromatin structures and thereby to
promote the formation of chromatin domain boundaries
at synthetic yeast and human cell telomeres [20,23,24].
We tested whether this may also occur at natural genomic
locations by partitioning the mouse genome into genomic
regions enriched or depleted of specific chromatin
modifications. Chromatin domain boundary (or barrier)
positions featuring sharp transitions of histone modifica-
tions were sorted and compared to the localization of
14,487 NFI-occupied sites. As a control set, we randomly
selected 14,487 genomic positions in the mouse genome,
taking from each chromosome the same number of ran-
dom loci as of the NFI-occupied sites. NFI-bound sites
were found to be significantly enriched near the boundary
regions of three different histone modifications character-
istic of expressed, accessible or silent chromatin, respect-
ively, namely H3K36me3, H3K4me3 and H3K27me3,
while randomly selected control genomic sequences were
distributed uniformly around these boundary positions
(Figure 4A-C).
From the locations of the distribution maxima, NFI
sites appeared to be located on the histone methylation-
enriched side of the boundaries. To address further this
possibility, we calculated the distances from the bound-
ary to the nearest NFI or random control site in both
orientations relative to the boundary. The distribution
plot of the first 2,000 smallest distances indicated that
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Figure 3 NFI associates with histone modification H3K4me3. In vivo NFI sites were defined with the threshold of 6 tags yielding 4,794 sites.
In vivo NFI sites were separated into two categories: one group (808 sites) mapping to regions +/− 5 kb from transcription start sites (TSS)
and another group outside these regions (3,986 sites). The average ChIP-Seq tag counts for different histone modifications were calculated in
windows of 100 bp for a region of 10 kb up- and down- stream of the in vivo NFI sites. Tag counts were normalized globally, as a fold-increase
over the genome average tag count in a window of 100 bp. In vivo Nanog sites were separated into two categories: mapping into regions +/−
5 kb from transcription start sites (TSS) and outside these regions. The average ChIP-Seq tag counts for different histone modifications were
calculated as for NFI. (A) In vivo NFI sites inside TSS +/− 10 kb. (B) In vivo NFI sites outside TSS +/−10 kb. (C) In vivo Nanog sites inside TSS +/−
10 kb. (D) In vivo Nanog sites outside TSS +/− 10 kb.
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http://www.biomedcentral.com/1471-2164/14/99NFI often bound the modification-rich side for all three
types of histone H3 modifications when compared to
the randomly selected sites (see Additional file 1: Figure
S13). An NFI site was found within 2.5 kb of the
modification-enriched side of 823 (2.8%), 549 (3.8%) and
1391 (4.4%) of the H3K27me3, H3K36me3 and H3K4me3
boundaries, respectively. An example of NFI binding a
boundary separating an open chromatin domain from
neighboring closed chromatin consists of the Blcap and
Nnat imprinted genes locus, where a H3K27me3-poor
and H3K36me3-enriched domain is bracketed by two
NFI-bound sites (Figure 4E). Additional examples of NFI-
associated boundaries are shown in the Additional file 1:
Figure S14.
The association of NFI with boundaries suggested that
it may indeed contribute to the formation of chromatin
barriers, but that its binding may not be sufficient to
promote boundaries at all genomic loci, as occupied
binding sites also occur within chromatin domains
(Figure 4E and Additional file 1: Figure S13). NFI-bound chromatin domain boundaries were often but
not always associated with promoters. For instance,
one of the NFI-bound boundaries was found to coin-
cide with the active Blcap gene promoter, as also indi-
cated by a high incidence of H3K4me3 modification
(Figure 4E). However, the other domain boundary
located 20 kb downstream of the Blcat gene showed a
relatively stronger NFI-binding site, which corresponds
to a consistently stronger histone H3K27me3 and
H3K36me3 modification boundary that does not bear
the H3K4me3 marks of promoters. Similar observations
were made at other genomic loci, suggesting that NFI
may separate transcribed and/or accessible portions of
the genome from silent chromatin (see Additional file 1:
Figure S14). We therefore assessed whether this may be
a general property of NFI-associated boundaries. From
29,158 boundaries of H3K27me3 modifications, 4,687
also featured an H3K36me3 modification boundary
(Table 1). Among the H3K27me3 and H3K36me3 over-
lapping boundaries, 148 (3.15%) were bound by NFI,
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Figure 4 NFI binding is associated with chromatin and nuclear lamina boundaries. The mouse genome was partitioned into histone
modification-poor and enriched segments, and the genomic positions of boundaries featuring transitions from modification-poor to enriched
regions were centered and aligned at position 0 of the X-axis, from (A) 14,632 H3K36me3 boundaries, (B) 31,662 H3K4me3 boundaries (C) 29,122
H3K27me3 modification boundaries. The distribution of 4,794 in vivo NFI sites was compared with the distribution of 4,794 randomly chosen
genomic positions sampled from each chromosome according to the number of occupied NFI sites. The average numbers of NFI or random sites
were normalized globally with the genome-wide average number of sites in 250 bp window. The distribution of NFI and random sites was also
aligned to the anchor spots of DNA to the nuclear lamina using 2 kb windows (D), where the arrows indicate the poor and enriched genomic
regions for the nuclear lamina lamin B component. (E) Example of NFI in vivo binding sites located at the boundaries of open and close
chromatin markers, H3K36me3 and H3K27me3, in mouse embryonic fibroblasts. NFI binding sites define the region of open chromatin
surrounding the Blcap and Nnat gene locus. NFI sites at the boundary positions are enclosed with a dotted line.
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Table 1 Distribution of NFI-C-occupied sites at H3K27me3 and H3K36me3 boundaries
29,158 H3K27me3 boundaries, subdivided in: Matching NFI-occupied site Matching random
genomic sites
P-value (binomial)
4,687 H3K27me3 boundaries co-localized with H3K36 boundaries 148 (3.15%) 45 (0.96%) 1.51e-14
2,032 H3K27me3 and H3K36me3 boundaries co-localized with TSS 35 (1.72%) 6 (0.29%) 7.84e-07
1,507 H3K27me3 and H3K36me3 boundaries co-localized with TES 21 (1.39%) 11 (0.72%) 0.050
1,148 H3K27me3 and H3K36me3 boundaries not co-localized with TES or TSS 92 (8.01%) 28 (2.43%) 1.11e-09
24,471 H3K27me3-only boundaries (not co-localized with H3K36 boundaries) 284 (1.16%) 253 (1.03%) 0.167
3,386 H3K27me3-only boundaries co-localized with TSS 67 (0.19%) 19 (0.05%) 5.29e-08
2,153 H3K27me3-only boundaries co-localized with TES 20 (0.09%) 13 (0.06%) 0.162
18,932 H3K27me3-only boundaries not co-localized with TES or TSS 197 (1.04%) 221(1.16%) 0.889
29,158 H3K27me3 modification boundaries were mapped over the murine genome using the ChIP-Part algorithm, and this dataset was intersected with the
H3K36me3 boundaries to yield co-localized or non-overlapping boundaries datasets. Boundaries were defined as co-localized if the sequences 2.5 kb up- and
down-stream from each boundary overlap by at least 1bp. Colocalization of NFI with the H3K27me3 and H3K36me3 boundaries, or H3K27me3-only boundaries,
was assessed using the set of 4,794 occupied sites or using the control set of 4,794 randomly selected genomic sequences. The percentages indicate the fraction
of the particular dataset indicated in the left column that overlaps either an NFI site or a randomly selected site.
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http://www.biomedcentral.com/1471-2164/14/99while just 45 (0.96%) co-localized with a control dataset
of 4,794 randomly selected genomic loci. This indicated
that the association of NFI with the double boundaries
does not result from fortuitous coincidence.
We next assessed whether the NFI-bound boundaries
are necessarily associated to the initiation or termination
of transcription. Among the 148 NFI-bound H3K27me3
and H3K36me3 boundaries, 35 (23%) overlapped a TSS
while 21 (14.1%) overlapped a transcription end site
(TES). Thus, the majority (62.9%) of these NFI-bound
double boundaries did not map to known transcriptional
initiation or termination sites (92 out of 148 double
boundaries, Table 1). From the 1,148 double boundaries
that are not localized at known TSS or TES, 92 (8.01%)
were bound by NFI, whereas only around 2.4% were found
to occur by random coincidence. This finding was specific
of the H3K27me3 and H3K36me3 double boundaries,
as a similar analysis of H3K27me3-only boundaries that
do not overlap TSS or TES did not reveal an enrichment
of NFI as compared to randomly selected genomic sites
(1.04% vs. 1.16%, Table 1). We therefore conclude
that most NFI-associated H3K27me3 and H3K36me3
boundaries cannot be simply ascribed to chromatin
modifications elicited by mRNA transcription, and that
over 90 of these double boundaries can result from NFI
binding alone. In the case of the Blcap and Nnat gene
locus, the H3K36me3–rich chromatin domain consists
mostly of DNA downstream of the Blcap gene
(Figure 4E). This downstream portion of the locus has
been shown to consist of a non-transcribed DNA region
that epigenetically regulates the methylation of the Nnat
promoter and its paternal allele- and tissue-specific
expression [46,47]. Whether some of the 92 NFI-bound
double boundaries may correspond to as yet unknown
imprinted loci remains to be evaluated.It has been proposed that physical connections of the
chromatin to the nuclear lamina may mediate boundaries
between open and closed chromatin structures in the
interphase nucleus [48,49]. Thus, we tested whether the
anchoring locations of DNA to the nuclear lamina may
also be enriched in in vivo occupied NFI sites, using DNA
interactions data for the lamin B1 component of nuclear
lamina in human fibroblasts. Genomic coordinates of
boundary regions, featuring transitions from the nuclear
lamina to the interior of the nucleus, were converted to
the mouse genome assembly mm9 using the liftOver tool
from UCSC. Out of 2,688 nuclear lamina boundaries,
2,470 could be successfully mapped to the equivalent
genomic locations on the mouse genome. NFI binding
occurred within 2.5 kb of 85 (or 3.4%) of the nuclear
lamina boundaries, and the occupied sites were located
predominantly over the lamin-poor side of the nuclear
lamina boundaries. However, unlike histone modification
boundaries, the occupied NFI sites were not specifically
enriched at the boundary position, as they occurred gener-
ally over the whole 100kbp of nuclear lamina-free genomic
regions extending away from the boundary (Figure 4D).
Thus, the occurrence of NFI at genomic boundaries corre-
lates with specific histone modifications that contribute to
gene expression regulation but not with structural boundar-
ies involving the nuclear lamina.
Active promoters contain preferred sites for NFI binding
The finding that the NFI-occupied binding sites often
coincide with TSS prompted us to analyze whether
particular promoters may preferentially associate with
this transcription factor and whether it may be linked to
promoter activity. NFI ChIP-Seq distribution showed
a 2-fold enrichment on the collection of all RefSeq
transcription start sites on the mouse genome, while
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http://www.biomedcentral.com/1471-2164/14/99predicted NFI sites were not over-represented at pro-
moters, except for very weak predicted sites (matrix
threshold 67) which showed a slight overrepresentation
at TSS (Figure 5A). This contrasts the CTCF transcrip-
tion factor, which showed a similar enrichment of both
ChIP-Seq tags and high score predicted site counts close
to TSS (Figure 5B). This indicated that NFI binding
sequences are not significantly enriched at mouseA
B
G
lo
ba
lly
 n
or
m
al
ize
d 
sit
e/
ta
g 
co
un
ts
 
-10 000 0 5 000 10 000
Distance from TSS (bp)
-5 000
CTCF ChIP-seq tags
CTCF predicted sites (70)
NF1 ChIP-seq tags
NF1 predicted sites (67)
0
0.5
1.0
1.5
2.0
G
lo
ba
lly
 n
or
m
al
ize
d 
sit
e/
ta
g 
co
un
ts
 
-10 000 0 5 000 10 000
Distance from TSS (bp)
-5 000
0
5
10
15
20
Figure 5 Increased NFI promoter association does not correlate
with high predicted affinity. Average NFI (panel A) or CTCF (panel
B) ChIP-Seq tag counts were calculated in windows of 100 bp for
regions 10kb up- and down- stream of the RefSeq annotated
transcription start sites (TSS). TSS were oriented and the broken
arrows indicate the initiation site and the direction of transcription.
Tag counts were normalized globally, as a fold increase over the
genome-wide average tag count in a window of 100bp. NFI and
CTCF predicted site counts were normalized similarly as a fold
increase over the genome average site count in a window of 100
bp using the indicated weight matrix cut-off scores.promoters as compared to intergenic and transcribed
regions, but that it is the association to the binding sites
per se that occurs preferentially at promoters. This may
possibly result from synergistic interactions with other
transcription factors and/or more permissive chromatin
structures that may occur at promoter regulatory
sequences, allowing NFI to interact with weak sites.
Consistently, NFI sites predicted to occur within 2 kb of
a TSS with a moderate to high affinity, with a weight
matrix threshold of 85, were associated to approxi-
mately 2-fold more ChIP-Seq tag counts than those
mapping away from TSS. Thus, we concluded that NFI
binding is favored at TSS for poorly- as well as for well-
conserved binding sequences.
We next assessed whether promoter activity may correl-
ate with NFI binding using microarray gene expression
data from wt C57Bl6 (wt) and NFI-C ko MEF cells [50].
3115 highly expressed genes (relative expression level >8)
and 4311 lowly or non-expressed genes (relative expres-
sion level <4) were selected from mRNA-profiling data
from NFIC-expressing cells. The group of lowly or non-
expressed genes did not show significant association with
NFI near their TSS, while highly expressed genes showed
the asymmetric profile seen for the total set of genes, with
a slight preference for the transcribed portion of the genes
(Figure 6A and 6B). As predicted sites were not overrepre-
sented at the TSS of either class of genes, we concluded
that NFI is preferentially bound to active promoters. Thus,
transcriptional activity may favor NFI binding through
synergistic interactions and/or a permissive chromatin
structure. Alternatively, but non-exclusively, the transcrip-
tional activity of these promoters may result at least in
part from NFI binding. However, the latter possibility
would leave open the question as to what would be driv-
ing NFI to bind to and to activate this subset of promoters
in the first place.NFIC as an activator of gene transcription
The association of NFI with H3K4me3- and H3K36me3-
enriched domains suggested that NFI may mediate gene
expression activation. To test this hypothesis, we first
divided mouse genes into 11 categories according to
their expression levels in MEF cells. NFI tag counts were
enriched over the promoters of highly expressed genes,
while it decreased following a linear trend towards the
group of the lowest expressed genes (Figure 6C and 6D).
When the RefSeq annotated genes containing one or more
in vivo NFI sites bound to their 5 kb upstream regions were
singled out from the genes not containing upstream NFI
sites (yielding 1,227 out of 21,772 RefSeq genes), NFI-
bound genes showed a higher average transcription level
than genes not associated to NFI (6.61 vs. 5.85, respectively,
p=2.91E-31, two tailed t-test). This indicated that NFI
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Figure 6 NFI tag count is increased near transcription start sites of highly-expressed genes. Average NFI ChIP-Seq tag counts were
calculated in windows of 200 bp for regions 10 kb up- and down- stream of the RefSeq annotated transcription start sites (TSS). TSS were
oriented and the broken arrows indicate the initiation site and the direction of transcription. Tag counts were normalized globally, as a fold
increase over the genome average tag count in a window of 200 bp. NFI predicted sites were mapped on the reference mouse genome mm9
with a matrix cut-off score 67. The NFI predicted site count was normalized in the same way, as a fold increase over the average site count in a
bin window of 200 bp. (A) Highly-expressed genes with Affymetrix expression levels greater than 8. (B) Low- or non- expressed genes with
Affymetrix expression levels lower than 4. Genes were separated into 11 groups according to their Affymetrix expression level (<3, 3–4, 4–5, 5–6,
6–7, 7–8, 8–9, 9–10, 10–11, 11–12, >12). (C) For each of these groups, the average NFI ChIP-Seq tag counts was calculated in windows of 200 bp
for regions 10 kb up- and down- stream of the RefSeq annotated transcription start sites (TSS). Tag counts were normalized globally, as a fold
increase over the genome average tag count in a window of 200 bp. (D) Peak maxima for each of the gene groups found at the TSS was plotted
against the expression level.
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http://www.biomedcentral.com/1471-2164/14/99protein family members may act mainly to activate tran-
scription when bound to promoters.
The transcriptional activation function of the NFI-C
family member was assessed from the mRNA profiling
data of the wt and NFI-C−/− ko cells, by comparing the
group of the 1000 genes most strongly up-regulated by
NFI-C to the group of the 1000 most down-regulated
genes. The changes of expression levels in these groups
indicated that NFI-C activated the expression of up-
regulated genes more than it decreased the expression of
down-regulated genes (data not shown). NFI-C-regulated
genes may be directly bound by NFI-C or indirectlycontrolled by e.g. the altered expression of NFI-C-regulated
transcription factors. Thus, we tested whether the NFI
group of proteins would bind preferentially NFI-C regu-
lated genes. As a control group of non-regulated genes,
we selected the 7,594 genes whose changes in expression
levels were affected by less than 5% when comparing wt
and ko cells. As additional control groups, we randomly
selected datasets of the same number of mouse genes. NFI
tag count was increased 3-fold over background on the TSS
of the 1,286 NFI-C up-regulated genes, and 2.6-fold for the
group of 862 NFI-C down-regulated genes (Figure 7). The
two control groups of NFI-C non-regulated genes showed
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Figure 7 Transcription start sites of NFI-C up-regulated genes show the highest occupancy with NFI. (A) Genes were considered to be
up-regulated by NFI-C if the difference in Affymetrix expression levels between wild-type and NFI-C knock-out cells was greater than 0.5. We
found 1286 genes to be up-regulated by NFI-C. As a negative control we used 1286 randomly chosen genes. (B) Genes were considered to be
down-regulated by NFI-C if the difference in Affymetrix expression level between wild-type and NFI-C knock-out cells was lower than −0.5. We
found 862 genes to be down-regulated by NFI-C. As a negative control we used 862 randomly chosen genes. In both graphs we used as a
negative control NFI-C non-regulated genes with the change in Affymetrix expression level between −0.05 and 0.05. Average NFI ChIP-Seq tag
counts were calculated in windows of 200 bp for regions 10 kb up- and down- stream of the oriented transcriptional start sites (TSS). TSS were
oriented and the broken arrows indicate the initiation site and the direction of transcription. Tag counts were normalized globally, as a
fold-increase over the genome average tag count in a window of 200 bp.
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http://www.biomedcentral.com/1471-2164/14/99consistent profiles, and a relatively lower 2.4-fold enriche-
ment of ChIP-seq tags over the TSS. When predicted site
occupancy was analyzed over up-regulated, non-regulated
or randomly selected genes, a preferential binding to
up-regulated genes was also observed (data not shown).
Overall, we conclude that NFI more prominently binds
the TSS of the up-regulated genes as compared to non-
regulated or down-regulated genes, implying that NFI is
a direct activator of a significant subset of the up-
regulated target genes.
What is the precise role of NFI-C in the up-regulation
of promoters bound by NFI family members, and what
happens at these promoters in the NFI-C ko cells? One
possibility is that these promoters are not bound by any
member of the NFI family in the ko cells. Alternatively,
they may be bound by less potent NFI activators. To
distinguish between these two hypotheses we analyzed
predicted site occupancy in the NFI ko cells in the same
manner as we did for the wild-type cells (see Additional
file 1: Figure S15). Plots obtained from wild-type and ko
cells are nearly identical, suggesting that there is no
change in overall NFI protein occupancy at NFI sites in
up-regulated promoters. This rules out member-specific
occupancy of NFI sites as an explanation for the ko
phenotype, and strongly favors the hypothesis that
different members of the NFI proteins have different
regulatory effects when bound to the same cis-regulatory
DNA element.Up-regulated genes had the highest density of occupied
sites when compared to the genome-wide average density
or to non-regulated genes (see Additional file 2: Table S4).
Consistently, up-regulated genes showed a higher density
of predicted sites than non-regulated genes (20.3 vs. 16.9
sites/Mb, respectively), indicating that preferential binding
to up-regulated genes depends at least in part upon a
higher density of genomic binding sequences. However,
an even higher density of predicted sites was observed on
intergenic sequences when compared to up-regulated
genes (22.5 vs. 20.3 sites/Mb, respectively), but the occu-
pancy of these sites were lower than that of upregulated
genes (5.2 vs. 7.9 sites/Mb, respectively). Thus, we con-
clude that NFI binding to up-regulated genes must be
dictated by both a higher density of high-affinity binding
sites and by a more permissive environment in terms of
cooperating transcription factors and/or chromatin
structure as opposed to intergenic locations in the
genome. Non-regulated genes show an intermediate
association to NFI (see Additional file 1: Figure S15),
indicating that they may be partly permissive for occu-
pation. Overall, these findings imply that the occurrence
of binding sites at non-genic locations is not subjected
to a negative selection pressure, which can be explained
by the fact that these sites are infrequently occupied and
thus would not divert these transcription factors from
binding target genes. However, binding sites appear to
be counter-selected at non-regulated genes, as expected
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structure permissive for NFI binding, and thus would
mediate improper regulation of non-target genes, and/
or compete for occupancy with physiologically-relevant
NFI target genes, should they contain proper binding
sequences.
Conclusions
In this study, we determined the DNA-binding specificity
and genome-wide distribution of NFI family proteins, and
we find that genomic binding site predictions correlate
well with DNA binding site specificity and with the
frequency of occupancy in living cells. However, we also
find that some high-scoring predicted sites are not occu-
pied, and conversely, that not every in vivo site contains a
strong predicted site in its vicinity. This indicates that
although the in vitro or in vivo DNA binding sequence
specificities are indistinguishable, the actual occupancy of
genomic binding sites may be influenced by the genomic
context, for instance by potential interactions with other
transcription factors and/or by the status of chromatin
modifications.
NFI binding to predicted sites was favored at promo-
ters that are enriched with the H3K4me3 chromatin
mark of active promoters, and notably at the promoters
of genes that are up-regulated by NFI-C. Gene bodies
and 3’UTRs are also more populated by occupied NFI
sites than intergenic regions. The distribution of NFI in
the genome is thus not uniform, while the distribution
of predicted binding sites is not biased in this respect.
Previous work suggested that NFI may act as a bound-
ary protein that separates distinct chromatin structures
at telomeric loci, and that it may directly interact with
nucleosomes on synthetic reporter promoters in trans-
fected cells. Nucleosome positioning on the mouse
mammary tumor virus promoter was associated to NFI-
mediated chromatin reorganization and promoter acti-
vation [22,51]. However, whether NFI may also interact
with nucleosomes and/or elicit chromatin domain
boundaries within a natural chromosomal context had
not been assessed so far. This ChIP-Seq study yielded
results consistent with a direct interaction of NFI with
nucleosomal particles. This observation is in agreement
with previous observations that the NFI trans-activation
domain can interact directly with the histone H3.3
variant in vitro, a marker of expressed genes and that it
alters the interaction of reconstituted nucleosomal cores
with DNA [19,52].
These findings also correlate well with another pro-
posed mode of action of NFI, which is to act as chroma-
tin boundary (or barrier) protein that can prevent the
spreading of closed chromatin conformation from the
telomeres upon subtelomeric positions [24]. Our data
indicate that NFI globally associates with chromatindomain boundaries separating permissive and silent
chromatin markers, as defined by its co-localization
with H3K27me3 and H3K36me3 boundaries of opposite
polarities. It has been previously reported that promoters
and/or CTCF sites often constitute chromatin domain
boundaries [53]. Consistently, we find that some of these
NFI-associated boundaries correspond to TSS. However,
we also observed NFI association with H3K27me3 and
H3K36me3 boundaries that do not map at TSS or TES, as
8% of such boundaries are bound by NFI. This is by far
the highest degree of correlation observed at such bound-
aries, indicating that this may be a prominent function
of NFI proteins. The proposed interaction of NFI with
nucleosomal particles may provide an explanation for
the previous observations that NFI histone-binding
domain blocks the propagation of silent chromatin
structures at human and yeast telomeres [20,23,24], where
this interaction might prevent the self-propagation of
histone modifications by the processive association of
histone-modifying enzymes to nucleosomes.
Overlaps of functionally distinct chromatin marks have
been observed previously, for instance in undifferentiated
cells where the co-localization of both open and closed
chromatin markers is termed bivalent chromatin [54].
Our results suggest that boundary proteins may specialize
in controlling the occurrence of particular combinations
of chromatin modifications, as indicated by the finding
that NFI associates preferentially with double H3K27 and
H3K36 boundaries, but not with simple H3K27 transi-
tions. One such NFI-bound boundary coincides with a
regulatory region required for the proper imprinting of
the Blcat and Nnat genomic locus, where two overlapping
genes are differentially expressed and imprinted during
murine and human development [47]. Interestingly, the
H3K36me3-rich domain bracketed by NFI binding sites
encompasses both these genes as well as a regulatory re-
gion that controls imprinting. Furthermore, misregulated
expression of the Nnat gene was observed during altered
tissue regeneration in NFI-C ko mice, suggesting this
locus as a bona-fide regulatory target of NFI-C [50].
Further large scale genomic studies will be required to as-
sess the intriguing possibility that such double boundaries
may be indicative of as yet unknown imprinted loci and
whether altered imprinting may contribute to some of the
developmental and tissue regeneration abnormalities
observed in NFI-C knock out mice [30,50,55].
Methods
Cell culture
Mouse embryonic fibroblasts (MEF) were extracted from
mouse embryos of 14.5 days. Cells from wild-type (WT)
and NFI-C knock-out (KO) embryos were cultured in
DMEM medium under the following conditions: 37°C, 5%
CO2, DMEM (GIBCO, 41966), Supplemental 10% FBS
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26140–079), 1% v/v nonessential amino-acids (GIBCO,
11140–035), 1% v/v L-glutamine (GIBCO, 25030–024).
Chromatin Immuno-precipitation (ChIP) and Western
blotting
Chromatin was extracted from approximately 20,000,000
cultured MEFs and cross-linked using 11% formaldehyde.
Extracted chromatin was fragmented to the average
fragment size of 1000 bp using high-frequency sound
sonication on VibraCell-75455 (Bioblock Scientific).
ChIP was performed as described previously [20], using
the commercial antibody against NFI group of proteins
(NFI (H300): sc-5567, SantaCruz Biotechnology). Antibody
complexes were precipitated using rProtein A Sepharose
Fast Flow (Amersham Biosciences). Western blot analysis
was performed using the same H300 commercial antibody.
Illumina/Solexa sequencing
ChIP DNA was processed using the contents of the ChIP-
Seq Sample Prep Kit (Illumina). Overhangs were con-
verted into phosphorylated blunt ends, using T4 DNA
polymerase, E. coli DNA Pol I large fragment (Klenow
polymerase), and T4 polynucleotide kinase (PNK). The 3'
to 5' exonuclease activity of these enzymes removes 3'
overhangs and the polymerase activity fills in the 5'
overhangs. ‘A’ base was added to the 3' end of the blunt
phosphorylated DNA fragments, using the polymerase
activity of Klenow fragment (3' to 5' exo minus). This
prepares the DNA fragments for ligation to the adapters,
which have a single ‘T’ base overhang at their 3' end.
Adapters were ligated to the ends of the DNA fragments,
preparing them to be hybridized to a flow cell. Excess
adaptors were removed and a size range of templates was
selected to go on the Cluster Station by loading the entire
sample on a 2% agarose gel and excising the gel region of
50-400 bp. PCR amplification of the gel-extracted DNA
was performed for 18 cycles using adapter-specific
primers. Each sample was loaded into 3 separate flow cell
channels of the Illumina Cluster Station and then
subjected to sequencing-by-synthesis on the Illumina
Genome Analyzer sequencing system.
Read alignment
Alignment of the obtained reads to the mouse reference
genome (mm9) was performed using ELAND software
(Illumina).
Data analysis
The ELAND software was used to filter out unmappable
tags, as well as those that occur on multiple loci in the
haploid genome, and the sequence tag positions were
mapped on the reference mm9 mouse genome (July
2007-NCBI37/mm9) allowing up to two mismatches.NFI binding sites were inferred from the mapped
sequence tags using the ChIP-Peak software tool from
the ChIP-Seq Analysis Server (URL: http://ccg.vital-it.
ch/chipseq/chip_peak.php) with the following para-
meters. As the average size of sequenced genomic DNA
fragments was around 260 bp (see Additional file 1:
Figure S16), to encompass tags from both ends of NFI
binding sites, the tags were counted in a sliding window
of 600 bp and we required a minimum distance of 600
bp (“vicinity range” parameters) between two NFI sites
to avoid counting the same site multiple times. Tags were
shifted 75 bp in their 5’-3’ direction (“centering options”),
prior to counting, and we counted only one tag per unique
genomic location (“count cut-off” parameter). The tag
threshold for defining NFI binding was set between five to
ten tags per window, as indicated, from an experimental
average tag density of 1 tag / 1204 bp and 1 tag /1291 bp
obtained from wt and NFI-C ko cells. For some types of
analyses, peaks falling into repeat regions annotated in the
UCSC RepeatMasker track were excluded. This was
achieved by activating the “Repeat Masker” checkbox on
the ChIP-Peak web form.
Correlation analyses of NFI ChIP-Seq tags and NFI
predicted sites were performed using the ChIP-Cor tool
available on the ChIP-Seq Analysis Server of the Swiss
Institute of Bioinformatics (URL: http://ccg.vital-it.ch/
chipseq/chip_cor.php). Partitioning of the mouse genome
into regions that are rich or poor in a particular histone
modification was performed using ChIP-Part tool from
the ChIP-Seq Analysis Server (URL: http://ccg.vital-it.ch/
chipseq/chip_part.php) using the following parameter
settings. Signal rich DNA stretches were defined with a
count density threshold of 0.004, the length of DNA
stretches was controlled with a transition penalty −20, and
the count cut-off of 5 was used to re-set higher tag counts
to the cut-off value. Scanning of in vivo NFI binding
sequences with the NFI weight matrix [29] was done using
the OPROF software tool from the Signal Search Analysis
server (URL: http://ccg.vital-it.ch/ssa/oprof.php). The
comprehensive scan of the mouse genome with the NFI
matrix was carried out with fetchGWI software [56]. Gen-
omic coordinates of chromatin and lamina boundaries
with the closest internal and external in vivo NFI sites are
deposited online at GEO database (accession number
GSE15844).
Galaxy tools [57] (URL: http://main.g2.bx.psu.edu/)
were used to calculate distribution statistics of in vivo
and predicted NFI sites in mouse intergenic and genic
compartments and to create intersections and subtrac-
tions of the genomic intervals from different datasets.
Galaxy lift-over tool was used to perform lift-over
of genomic coordinates of LAD domains from the
human genome (version hg18) to the mouse genome
(version mm9).
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random genomic positions were performed using
custom-made C++ scripts, available upon request (Pjanic
et al., 2011).
Motif analysis
MEME software [58] was used to search for over-
represented motifs within sets of sequences extrac-
ted +/−125 bp from the strongest in vivo sites from
wild-type and NFI-C knock-out mouse embryonic
fibroblasts. MEME parameters were the following: any
number of repetitions per sequence, 5 bp minimum
motif width, 20 bp maximum motif width, minimum
number of repetitions for each motif - 20, maximum
number of repetitions for each motif - 300. Binding
sites weight matrices were also generated by hidden
Markov training using MAMOT software [59]. The
consensus sequence TTGGCNNNNNCGAA was used
as starting model. Details of the protocol can be found
in [29].
Datasets repository
NFI ChIP-Seq data from wild type and NFI-C knock-out
mouse embryonic fibroblasts, as well as sequenced in-
put control DNA, were deposited at Gene Expression
Omnibus (GEO) repository under the accession number
GSE15844. Gene expression microarray data for mouse
embryonic fibroblasts were taken from GEO repository
under the accession number GSE15871. ChIP-Seq data
for histone modifications H3K4me3, H3K27me3,
H3K36me3 in mouse embryonic fibroblasts were
obtained from GEO repository under the accession
number GSE12241. Genomic coordinates of lamina
associated domains (LAD) from Tig3 human fibroblast
cells were downloaded as a publication Supplemental
data [49], at the following URL: http://www.nature.com/
nature/journal/v453/n7197/suppinfo/nature06947.html.
Genomic coordinates of micro RNA precursors in the
mouse genome were obtained as a publication Supple-
mental data [45], at the URL: http://www.cell.com/
supplemental/S0092-8674(08)00938-0.
Predicted NFI sites from the mouse genome (ver. mm9)
based on the SELEX-SAGE derived position weight matrix
[29] are deposited as bed files at the URL: http://ccg.vital-it.
ch/BED/CTF-NF1/. Multiple site collections defined with
different matrix cut-offs ranging from 67 – 90 score units
are provided for each chromosome.
Additional files
Additional file 1: Figure S1. Number of predicted genomic NFI
binding sites as a function of the position weight matrix score threshold.
Figure S2. NFI predicted sites in the vicinity of in vivo occupied sites -
effect of different tag threshold values for defining in vivo binding sites.Figure S3. NFI ChIP-Seq tags preferentially map to the vicinity of NFI
predicted sites – effect of lowering the weight matrix score cut-off.
Figure S4. Comparison of ChiP-Peak and MACS algorithms for peak
calling in ChIP-Seq experiments. Figure S5. Tags mapping on plus and
minus strands are symmetrically distributed around NFI predicted sites.
Figure S6. Sequence analysis of NFI in vivo sites from wild-type and
knock out mouse embryonic fibroblasts. Figure S7. NFI-C knock-out
mouse embryonic fibroblasts show reduction in NFI protein levels and
occupancy of predicted sites. Figure S8. Positional correlation between
plus and minus tags corresponds to the NFI –DNA complex length.
Figure S9. Positional correlation of tags mapping on plus and minus
strand from unprecipitated control dataset. Figure S10. Atomic force
microscopy assay of the length of DNA fragments generated by the
sonication of crosslinked chromatin. Figure S11. Proposed mode of
interaction of NFI and nucleosomal particles based on the ChIP-Seq
analysis. Figure S12. NFI in vivo-occupied sites at miRNA TSS colocalize
with H3K4Me3 and H3K36me3 modifications. Figure S13. Distribution of
distances from histone modification boundaries to the closest NFI or
randomly selected site. Figure S14. NFI in vivo sites are often located
near chromatin domain boundaries. Figure S15. NFI predicted sites are
more frequently occupied at NFI-C up-regulated genes. Figure S16.
Average ChIP DNA fragment length submitted for sequencing with the
Illumina Genome Analyzer.
Additional file 2: Table S1. DNA motifs found with the program
peak-motifs in peak lists obtained with different tag thresholds.
Table S2. Distribution of in vivo and matrix-predicted NFI sites on the
mouse genome. Table S3. Distribution of NFI in vivo sites surrounding
miRNA loci. Table S4. Predicted and occupied site distribution at NFI-C
-regulated and non-regulated genes.
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